Financhill
Back

ProShares Ultra 20+ Year Treasury Vs. Avidity Biosciences Industry Stock Comparison

Sell
40

UBT
ProShares Ultra 20+ Year Treasury

Last Price:
18.07
Seasonality Move:
2.86%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
40
ProShares Ultra 20+ Year Treasury (UBT) is a Sell

Is ProShares Ultra 20+ Year Treasury a Buy, Sell or Hold?

  • The current ProShares Ultra 20+ Year Treasury [UBT] share price is $18.03. The Score for UBT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • UBT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UBT Stock Price Chart

What is ProShares Ultra 20+ Year Treasury's stock price today?

  • The ProShares Ultra 20+ Year Treasury share price today is $18.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBT is experiencing slight selling pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

UBT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 36.79 Sell
Chaikin Money Flow: -12168 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.37 - 19.51) Sell
Bollinger Bands (100): (18.97 - 21.69) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

UBT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.41 Sell
20-day SMA: 18.71 Sell
50-day SMA: 20.24 Sell
200-day SMA: 19.82 Sell
8-day EMA: 18.38 Sell
20-day EMA: 18.82 Sell
50-day EMA: 19.63 Sell
200-day EMA: 20.23 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

ProShares Ultra 20+ Year Treasury Earnings Growth & UBT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

ProShares Ultra 20+ Year Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):